|Videos|April 27, 2022

Aurion BioTech presents cell therapy findings with published clinical data

Author(s)Kassi Filkins

Greg Kunst, president and CEO of Aurion BioTech, shares a company update on endothelial cell therapy trials, clinical plans and upcoming data.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME